, 2019 as follows: Management Discussion and Analysis For the 9 Months Period Ended 30 September 2019 Summary of Performance Sales Revenue For the period of nine months ended 30 September 2018 and 2019

called “The Group”) would like to submit Management’s discussion and analysis for the Quarter ’ with the summary as follows: - 1. Nature of operations of the Group The Group has principally engaged in

recognition WCIH as subsidiary company. 3 2. Financial Performance Summary – by business Revenues by business Baht’000 Consolidated 2019 2018 ∆% Distributor of medical devices and equipment 1,736,795 1,828,053

follows: Management Discussion and Analysis For the three months ended March 31, 2020 Summary of Performance Sales Revenue For the three months ended 31 March 2019 and 2020, the Company recorded total sales

(Hereinafter called “The Group”) would like to submit Management’s discussion and analysis for Quarter 1’ 2020 with the summary as follows: - 1. Nature of operations of the Group The Group has principally

-1- AIT (VP-SEC) 022E/2022 August 11, 2022 Subject: Management's Discussion and Analysis of Operating Results for Q2-2022 To: The President of the Stock Exchange of Thailand Summary of Operations Q1

other assets to the unitholders, the management company, the fund supervisor and other related persons as well as the person who is responsible for the expenses for the debt performance; (2) provision on

Summary of Rules on Mutual Recognition of Funds between Hong Kong Special Administrative Region of the People’s Republic of China and Thailand (HK-TH MRF) 1. Offerings for sale of Hong Kong Covered

the Company and its subsidiaries within 21 days from the date of the Company inform to the Stock Exchange of Thailand according to the Acquisition or Disposal of Assets Notifications. Summary of the

set up additional expected credit loss amount at a higher level when comparing to 1Q20. 4 Summary of operating performance Unit : Baht million 1Q21 4Q20 % QoQ 1Q20 % YoY Net Interest income 3,830 3,996